News & Articles
Selected Filters:
Compliant analysis without helium: Malvern Panalytical launches even smarter Epsilon 1
The Epsilon 1 is the first analytical solution for this purpose without the need for helium
9 new resources to advance your biopharmaceutical research
Explore expert webinars, free downloads, latest methods, and much more to help support biopharmaceutical research
Explore hot topics at these 10 free webinars coming up this week
Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D
Researchers develop handheld ‘lab on chip’ Covid test that gives results in 10 minutes
New smartphone-sized test device uses innovative ‘lab on chip’ technology for rapid, accurate results
Siemens Healthineers lab-based antigen test available on high-throughput analyzers to support COVID-19 testing
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples
Mission Bio’s Tapestri Platform used to distinguish acute myeloid leukemia clones from CHIP clones
New findings pave way to potentially improved assessment of measurable residual disease in AML patients
Manchester scientists accelerate path for making COVID-19 drugs
The research describes a new family of enzymes for pharmaceutical production
Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID
The Allplex SARS-CoV-2 Master Assay can detect a total of 10 targets including four coronavirus genes
Seegene’s COVID-19 test can simultaneously target 4 genes of SARS-CoV-2 and recognize multiple virus variants
Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min
The breakthrough technology transforming RNA detection
Dr. Boye Schnack Nielsen shares tips for running successful in situ hybridization assays as he provides insights on how RNA detection methods have evolved over time
Bio-Rad expands its COVID-19 offering with the Coronavirus Ag Rapid Test
The antigen test is used to detect the nucleocapsid protein antigen in SARS-CoV-2
Optibrium and BioPharmics have entered partnership on computational drug design
Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimization software
FUJIFILM Irvine Scientific celebrates 50 years of excellence in cell culture
Innovation and growth remain a priority to support customers and COVID-19 initiatives
DiaSorin releases assay for rapid identification of SARS-CoV-2 variants
The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction
Beckman Coulter launches a fully automated COVID-19 IgG test to assess antibody immune response levels
The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods
binx health submits request for Emergency Use Authorization for first CRISPR-based point-of-care test for COVID-19
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
Increasing SARS-CoV-2 testing capacity with CRISPR-based rapid testing
Genome editing experts harness the power of CRISPR-Cas enzymes to power the next diagnostic revolution in COVID-19 detection and diagnosis
Transform your pharmaceutical workflow with cutting-edge chromatography data management
Find out how to meet tough quality control and assurance regulations with the latest resources, new methods, and exclusive interviews
Biopharmaceuticals webinar series: Explore the latest trends in biopharmaceutical research and development
In this series of webinars, discover the latest techniques and technologies helping researchers advance their biopharmaceuticals workflows























